AI English summary of an SEC filing — figures as filed
CVS Health CVSThe company said its board appointed Brian O. Newman as Executive Vice President and Chief Financial Officer on April 7, 2025, effective May 12, 2025. He will serve as Chief Financial Officer Designate from April 21, 2025 until the effective date.
Key points
AI summaryThe company said its board appointed Brian O. Newman as Executive Vice President and Chief Financial Officer on April 7, 2025, effective May 12, 2025. He will serve as Chief Financial Officer Designate from April 21, 2025 until the effective date.
Newman will receive an annual base salary of $1.0 million, a target annual cash bonus of 150% of his base salary, and a target annual equity award of $7.0 million, the company said. It said Newman will not receive a sign-on award. He served as Executive Vice President and Chief Financial Officer of UPS from September 2019 to May 2024.
The company said Thomas F. Cowhey, the current Executive Vice President and Chief Financial Officer, will step down from that role effective May 12, 2025. He will then serve as Strategic Advisor to the President and Chief Executive Officer and help with the transition of his duties. The date of his departure has not been determined, the company said.
CVS Health said its board appointed Amy L. Compton-Phillips, M.D., as Executive Vice President and Chief Medical Officer on April 7, 2025, effective May 19, 2025. The role was previously held by Sreekanth K. Chaguturu, M.D., who was named Executive Vice President and President, Health Care Delivery in November 2024.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Appointment of Brian O. Newman as Chief Financial Officer
The company said its board appointed Brian O. Newman as Executive Vice President and Chief Financial Officer on April 7, 2025, effective May 12, 2025. He will serve as Chief Financial Officer Designate from April 21, 2025 until the effective date.
Source · Based on the filing body and exhibits
Newman's Compensation Terms and Background
Newman will receive an annual base salary of $1.0 million, a target annual cash bonus of 150% of his base salary, and a target annual equity award of $7.0 million, the company said. It said Newman will not receive a sign-on award. He served as Executive Vice President and Chief Financial Officer of UPS from September 2019 to May 2024.
Source · Based on the filing body and exhibits
Thomas F. Cowhey's Transition to a Strategic Role
The company said Thomas F. Cowhey, the current Executive Vice President and Chief Financial Officer, will step down from that role effective May 12, 2025. He will then serve as Strategic Advisor to the President and Chief Executive Officer and help with the transition of his duties. The date of his departure has not been determined, the company said.
Source · Based on the filing body and exhibits
Appointment of Amy L. Compton-Phillips as Chief Medical Officer
CVS Health said its board appointed Amy L. Compton-Phillips, M.D., as Executive Vice President and Chief Medical Officer on April 7, 2025, effective May 19, 2025. The role was previously held by Sreekanth K. Chaguturu, M.D., who was named Executive Vice President and President, Health Care Delivery in November 2024.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…